# GnRH Agonist and Intrauterine Insemination

> **NCT00503217** · PHASE4 · COMPLETED · sponsor: **Instituto Valenciano de Infertilidad, IVI VALENCIA**

## Conditions studied

- Intrauterine Insemination

## Interventions

- **DRUG:** Tryptorelin

## Key facts

- **NCT ID:** NCT00503217
- **Lead sponsor:** Instituto Valenciano de Infertilidad, IVI VALENCIA
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** — (—)
- **Last updated:** 2016-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503217, "GnRH Agonist and Intrauterine Insemination". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00503217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*